Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Go back to Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101
(NASDAQ: ERNA) Delayed: 4.45 --0 (-0%)
Previous Close $4.45    52 Week High
Open $4.45    52 Week Low
Day High $4.45    P/E N/A 
Day Low $4.45    EPS
Volume 3,085